National Cancer Institute
Cancer Imaging Program

Development of Clinical Imaging Drugs & Enhancers (DCIDE)
Last Updated: 05/24/2007

This page lists current opportunities from CIP, as well as other NCI and NIH cancer imaging initiatives, including grant mechanisms where industry is encouraged to apply.

For information on funding opportunities that are now closed, go to Past Funding Opportunities 1.

For information about the funding process, go to Mechanisms 2 or Guidelines 3.

The NCI's Division of Extramural Activities provides information about newly approved concepts, which may become RFAs and PAs. Check the Concepts Cleared at the NCI Board of Scientific Advisors Meeting 4 web site for the earliest possible information about future initiatives.

The Division of Extramural Activities displays NCI Sponsored Research Initiatives 5.

Current Funding Opportunities 6 7

CONTINUED DEVELOPMENT AND MAINTENANCE OF SOFTWARE (R01) (MULTIPLE IC'S) (PAR-08-010) 8

  • Release/Posted Date: October 18, 2007
  • Letter of Intent Receipt Date: November 17, 2007
  • Application Receipt Date(s): January 17, 2008; May 21, 2008; September 22, 2008; January 22, 2009; May 22, 2009; September 22, 2009; January 22, 2010; May 21, 2010; September 22, 2010
  • NCI Contact: Jennifer Couch, Ph.D.; Tel. 301-435-5226; E-mail: couchj@mail.nih.gov 9
  • Expiration Date: September 23, 2010

NEUROIMAGING INFORMATICS SOFTWARE ENHANCEMENT FOR IMPROVED INTEROPERABILITY AND DISSEMINATION (multiple institutes) (R03) (PAR-07-417) 10

  • Release/Posted Date: July 25, 2007
  • Letters of Intent Receipt Date(s): August 24, 2007; December 15, 2008; April 15, 2008; August 15, 2008, December 15, 2009; April 15, 2009; August 15, 2009; December 15 2010; and April 14, 2010
  • Application Submission/Receipt Date(s): September 24, 2007; January 15, 2008; May 15, 2008; September 15, 2008, January 15, 2009; May 15, 2009; September 15, 2009; January 15 2010; and May 14, 2010
  • Contact: Zohara Cohen, Ph.D., Tel: 301-451-4778; E-mail: zcohen@mail.nih.gov 11
  • Expiration Date: May 15, 2010

CLINICAL CANCER THERAPY AND PREVENTION RESEARCH (R01) (PA-07-356) (NCI) 12

  • Release Date: April 16, 2007
  • Application Receipt/Submissions Dates: Standard dates
  • Contact: Keyvan Farahani, Ph.D., NCI, Phone: 301-496-9531, Email: farahank@mail.nih.gov 13
  • Expiration Date: May 8, 2010

DEVELOPMENT OF ASSAYS FOR HIGH-THROUGHPUT DRUG SCREENING (NIDDK, NCI, NIAID, NIMH) (R01) (PA-07-320) 14

  • Release Date: March 19, 2007
  • Application Receipt Dates: Standard Dates
  • Contact: Min H. Song, Ph.D., NCI, Phone: 301-496-8783, Email: ms425z@nih.gov 15
  • Expiration Date: May 8, 2010


PAR-07-352: Bioengineering Research Partnerships (BRP) [R01] (Multiple ICs) 16

  • Release Date: April 6, 2007
  • Application Receipt Dates: Standard Dates
  • No set-aside
  • Contact: Albert Lee, Ph.D., NIBIB, Phone: 301-451-4781, Email: alee@mail.nih.gov 17
  • Expiration Date: May 8, 2010


Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery (R01) (NCI) (PA-07-260) 18

  • Release/Posted Date: December 21, 2006
  • Application Submission/Receipt Date(s): Standard dates apply
  • Contact: Louise Wideroff, Ph.D., NCI, Phone: 301-435-6823, Email: wideroff@nih.gov 19
  • Expiration Date: January 3, 2009

Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows (F33) (PA-07-172) 20

Pathogenesis And Treatment Of Lymphedema And Lymphatic Diseases (R01) (PA-07-165) 21

  • Release/Posted Date: December 14, 2006
  • Application Receipt/Submission Date(s): Multiple dates, see announcement
  • Contact: Suresh Mohla, Ph.D., NCI, Phone: 301-435-1878, Email: mohlas@mail.nih.gov 22
  • Expiration Date: December 31, 2009, unless reissued

Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research (PA-07-106) 23

Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (F32) (PA-07-107) 24

Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases (R01) (NIDDK) (PA-07-025) 25

Research Project Grant (Parent R01) (PA-07-070) 26

This is the notice for the generic R01 for use in the electronic application.


PA-07-279: Bioengineering Research Grants (BRG)(R01) 27

  • Release/Posted Date: January 8, 2007
  • Application Receipt Dates: Standard Dates Apply
  • Contact: Houston Baker, Ph.D., NCI, Phone 301-594-9117, Email: bakerhou@mail.nih.gov 28
  • Expiration Date: January 8, 2010

PA-06-418: Exploratory/Developmental Bioengineering Research Grants(EBRG) [R21] 29

PAR-06-451: Quick-Trials for Novel Cancer Therapies: Exploratory Grants (R21) 30

  • Release/Posted Date: June 9, 2006
  • Application Receipt/Submission Date(s): August 9, 2006; December 9, 2006; April 9, 2007; July 9, 2007; November 9, 2007
  • Contact: Dr. Roy Wu, NCI, Phone: 301-496-8866, Email: wur@ctep.nci.nih.gov 31
  • Expiration Date: December 10, 2007 (unless reissued)
  • Reissued as PAR-08-025
  • New Expiration Date: November 10, 2010


PA-08-050: PHS 2008-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) 32

  • Release/Posted Date: January 25, 2008
  • Application receipt dates: April 5, August 5, December 5, 2008
  • Contact: Keyvan Farahani, Ph.D., NCI, Phone: 301-451-2651, Email: farahank@mail.nih.gov 13
  • Expiration date: January 8, 2009

PA-07-297: NIH Pathway to Independence (PI) Award (K99/R00) 33

  • Release Date: January 12, 2007
  • Application Receipt Dates: standard dates
  • Contact: David J. Eckstein, Ph.D., NCI, Phone: 301-496-8580, Email: Eckstein@mail.nih.gov 34
  • Expiration date: January 3, 2010


PA-08-051: PHS 2008-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) 35

  • Release/Posted Date: January 16, 2008
  • Application receipt dates: April 5, August 5, December 5, 2008
  • Contact: Keyvan Farahani, Ph.D., NCI, Phone: 301-451-2651, Email: farahank@mail.nih.gov 13
  • Expiration date: January 8, 2009

PAR-08-034: Solicitation of assays for high throughput screening (HTS) in the molecular libraries screening centers network (X01) 36

  • Release/Posted Date: November 30, 2007
  • Letters of Intent Receipt Date(s): Dec. 30, 2007; Apr. 23, 2008; Aug. 26, 2008; Dec. 23, 2008; Apr. 22, 2009; Aug. 24, 2009; Dec. 26, 2009; Apr. 26, 2010; and Aug. 24, 2010
  • Application Submission Date(s):Jan. 30, 2008; May 23, 2008; Sept. 26, 2008; Jan. 23, 2009; May 22, 2009; Sept. 24, 2009; Jan. 26, 2010; May 26, 2010; and Sept. 24, 2010.
  • Contact: Ingrid Li, Ph.D,, Molecular Libraries Assay Access Team, Phone: (301) 443-5288, Email: ili1@mail.nih.gov 37
  • Expiration Date: September 25, 2010

PAR-09-218: Innovations in Biomedical Computational Science and Technology (R01) 38

  • Release/Posted Date: August 5, 2009
  • Application Receipt Date(s): Standard dates apply
  • Contact: Peter Lyster, Ph.D., NIGMS, Phone: 301-451-6446, Email: lysterp@mail.nih.gov 39
  • Expiration Date: September 8, 2012

PA-09-043: Mentored Patient-Oriented Research Career Development Award (K23) 40

PA-10-009 Bioengineering Research Grants (BRG)(R01) 41

  • Release/Posted Date: October 14, 2009
  • Application Receipt Dates: Standard Dates Apply
  • Contact: Houston Baker, Ph.D., NCI, Phone 301-594-9117, Email: bakerhou@mail.nih.gov 28
  • Expiration Date: January 8, 2013.

PA-08-226: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) 42

PAR-08-055: Cancer Prevention Research Small Grant Program (R03) 43

  • Release/Posted Date: December 17, 2007
  • Application Receipt Dates: March 19, July18, December 19, 2008; March 20, July 17, December 18, 2009; March 19, July 19, December 9, 2010
  • Contact: Lynn Sobara, Ph.D., Tel: (301) 435-0584; Email: LynnS@mail.nih.gov 44
  • Expiration Date: December 10, 2010

    		•

    PAR-08-120: Cancer Education Grants Program (R25) 45

  • Release/Posted Date: March 28, 2008
  • Application Receipt Dates:standard dates apply
  • Contact: Lester Gorelic, Ph.D., Tel: (301) 496-8580; Email: gorelicl@mail.nih.gov 46
  • Expiration Date: September 8, 2011

    		•

    PA-09-081: PHS 2009-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) 47

    Nanoscience and Nanotechnology in Biology and Medicine (R01: PAR-08-052); (R21: PAR-08-053) 48

  • Release Date: December 18, 2007
  • Application Submission/Receipt Dates: Standard dates apply
  • Contact: Piotr Grodzinski grodzinp@mail.nih.gov 49
  • Expiration Date: January 8, 2011

    		•

    PA-08-243:Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01) 50

    • Release/Posted Date: August 19, 2009
    • Application Submission/Receipt Date(s): Standard dates apply
    • Contact: Heng Xie, M.D., M.P.H., Ph.D., NCI, Phone: 301-496-8866 Email: XieHe@mail.nih.gov 51
    • Expiration Date: September 8, 2011

    PA-08-098: Functional Links between the Immune System, Brain Function and Behavior (R21) 52

    • Release/Posted Date: March 4, 2008
    • Application Receipt/Submission Date(s): Standard dates
    • Contact at NCI: Paige McDonald, Ph.D., MPH, Phone: 301-435-5037, Email: mcdonalp@mail.nih.gov 53
    • Expiration Date: May 17, 2011

    PAR-09-251:Optimization of Small Molecule Probes for the Nervous System (R21) 54

      STTR (PAR-09-259) and SBIR (PAR-09-260) versions are also available.
    • Release Date: August 13, 2009
    • Application Submission Date(s): Standard dates apply
    • Contact: Mark Scheideler, Ph.D., Phone: 301-496-1779, Email: scheidelerm@ninds.nih.gov 55
    • Expiration Date: September 8, 2012

    PAR-09-088: Established Investigator Award in Cancer Prevention & Control (K05) 56

    • Release Date: January 22, 2009
    • Application Receipt Dates: Standard dates apply for K award
    • Contact: Shannon M. Lemrow, Ph.D., NCI, Phone: 301-496-8580, Email: lemrows@mail.nih.gov 57
    • Expiration Date: January 8, 2012

    PAR-09-219: Exploratory Innovations in Biomedical Computational Science and Technology (R21) 58

    • Release/Posted Date: August 17, 2009
    • Application Receipt/Submission Date(s): Standard dates.
    • Contact: Peter Lyster, Ph.D., NIGMS, Phone: 301-451-6446, Email: lysterp@mail.nih.gov 39
    • Expiration Date:September 8, 2012

    PA-10-010: Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) 59

  • Release/Posted Date: October 14, 2009
  • Application Receipt Dates: Standard Dates Apply
  • Contact: Houston Baker, Ph.D., NCI, Phone 301-594-9117, Email: bakerhou@mail.nih.gov 28
  • Expiration Date: January 8, 2013

    		•

    PAR-09-089: The NCI Transition Career Development Award (K22) 60

    • Release Date: January 23, 2009
    • Application Submission Date(s): Standard dates apply
    • Contact: Sonia Jakowlew, Ph.D., Phone: 301-496-8580, Email: jakowles@mail.nih.gov 61
    • Expiration Date: January 8, 2012

    PAR-09-220, 221: Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44]), (STTR {R41/R42)] 62

    • Release/Posted Date: August 5, 2009
    • Application Receipt Date(s): Standard dates apply
    • Contact: Peter Lyster, Ph.D., NIGMS, Phone: 301-451-6446, Email: lysterp@mail.nih.gov 39
    • Expiration Date: September 9, 2012

    PA-09-042: Mentored Clinical Scientist Research Career Development Award (K08) 63

    • Release Date: December 11, 2008
    • Application Receipt/Submission Date(s): Multiple dates, see announcement
    • Dorkina Myrick, M.D., Ph.D. (NCI), Phone: 301-496-8580, Email: Myrick@mail.nih.gov 64
    • Expiration Date:January 8, 2012

    PA-09-080: PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) 65


    Table of Links

    1http://dev1.cancer.gov/researchfunding/past/pastfunding
    2http://dev1.cancer.gov/researchfunding/mechanisms
    3http://dev1.cancer.gov/researchfunding/ApplicationGuidelines
    4http://deainfo.nci.nih.gov/concepts/recentcleared.htm
    5http://deainfo.nci.nih.gov/funding.htm
    6http://dev1.cancer.gov/researchfunding/current/currentfunding
    7http://dev1.cancer.gov/researchfunding/current/currentfundingother
    8http://dev1.cancer.gov/researchfunding/current/PAR-08-010
    9couchj@mail.nih.gov
    10http://dev1.cancer.gov/researchfunding/current/PAR-07-417
    11zcohen@mail.nih.gov
    12http://dev1.cancer.gov/researchfunding/current/PA-07-356-2
    13farahank@mail.nih.gov
    14http://dev1.cancer.gov/researchfunding/current/PA-07-320
    15ms425z@nih.gov
    16http://dev1.cancer.gov/researchfunding/current/PAR-07-352
    17alee@mail.nih.gov
    18http://dev1.cancer.gov/researchfunding/current/PA-07-260
    19wideroff@nih.gov
    20http://dev1.cancer.gov/researchfunding/current/PA-07-172
    21http://dev1.cancer.gov/researchfunding/current/PA-07-165
    22mohlas@mail.nih.gov
    23http://dev1.cancer.gov/researchfunding/current/PA-07-106
    24http://dev1.cancer.gov/researchfunding/current/PA-07-107
    25http://dev1.cancer.gov/researchfunding/current/PA-07-025
    26http://dev1.cancer.gov/researchfunding/current/PA-07-070
    27http://dev1.cancer.gov/researchfunding/current/PA-07-279
    28bakerhou@mail.nih.gov
    29http://dev1.cancer.gov/researchfunding/current/PA-06-418
    30http://dev1.cancer.gov/researchfunding/current/PAR-06-451
    31wur@ctep.nci.nih.gov
    32http://dev1.cancer.gov/researchfunding/current/PA-08-050
    33http://dev1.cancer.gov/researchfunding/current/PA-07-297
    34Eckstein@mail.nih.gov
    35http://dev1.cancer.gov/researchfunding/current/PA-06-121
    36http://dev1.cancer.gov/researchfunding/current/PAR-08-034
    37ili1@mail.nih.gov
    38http://dev1.cancer.gov/researchfunding/current/PAR-09-218
    39lysterp@mail.nih.gov
    40http://dev1.cancer.gov/researchfunding/current/pa-09-043
    41http://dev1.cancer.gov/researchfunding/current/pa-10-009
    42http://dev1.cancer.gov/researchfunding/current/PA-08-226
    43http://dev1.cancer.gov/researchfunding/current/PAR-08-055
    44Lynns@mail.nih.gov
    45http://dev1.cancer.gov/researchfunding/current/PAR-08-120
    46gorelicl@mail.nih.gov
    47http://dev1.cancer.gov/researchfunding/current/PA-09-081
    48http://dev1.cancer.gov/researchfunding/current/PA-08-052
    49grodzinp@mail.nih.gov
    50http://dev1.cancer.gov/researchfunding/current/pa-08-243
    51XieHe@mail.nih.gov
    52http://dev1.cancer.gov/researchfunding/current/pa-08-098
    53mcdonalp@mail.nih.gov
    54http://dev1.cancer.gov/researchfunding/current/PAR-09-251
    55 scheidelerm@ninds.nih.gov
    56http://dev1.cancer.gov/researchfunding/current/PAR-09-088
    57lemrows@mail.nih.gov
    58http://dev1.cancer.gov/researchfunding/current/PAR-09-219
    59http://dev1.cancer.gov/researchfunding/current
    60http://dev1.cancer.gov/researchfunding/current/PAR-09-089
    61jakowles@mail.nih.gov
    62http://dev1.cancer.gov/researchfunding/current/PAR-09-220
    63http://dev1.cancer.gov/researchfunding/current/PA-09-042
    64yrick@mail.nih.gov
    65http://dev1.cancer.gov/researchfunding/current/PA-09-080